- Home
- MIAC vs RNAC Comparison
MIAC vs RNAC Comparison
Compare MIAC & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MIAC | RNAC |
|---|---|---|
| Founded | 2026 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 247.0M | 218.4M |
| IPO Year | 2026 | 2016 |
Fundamental Metrics
Financial Performance| Metric | MIAC | RNAC |
|---|---|---|
| Price | $9.81 | $6.73 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $33.67 |
| AVG Volume (30 Days) | ★ 118.7K | 104.2K |
| Earning Date | N/A | 11-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,797,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.79 | $5.60 |
| 52 Week High | $9.93 | $11.00 |
Technical Indicators
Market Signals| Indicator | MIAC | RNAC |
|---|---|---|
| Relative Strength Index (RSI) | 56.08 | 50.34 |
| Support Level | $9.80 | $5.90 |
| Resistance Level | $9.93 | $7.50 |
| Average True Range (ATR) | 0.01 | 0.41 |
| MACD | 0.00 | 0.10 |
| Stochastic Oscillator | 100.00 | 70.59 |
Price Performance
Historical ComparisonAbout MIAC Meridian3 Industrials Acquisition Corp Class A Ordinary Shares
Meridian3 Industrials Acquisition Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.